<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21427" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Excimer Laser Coronary Angioplasty</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahmood</surname>
            <given-names>Uzair A.</given-names>
          </name>
          <aff>University of Kansas Health System</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hajj</surname>
            <given-names>Georges</given-names>
          </name>
          <aff>University of Kansas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Uzair Mahmood declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Georges Hajj declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21427.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Excimer laser coronary angioplasty (ELCA) is a safe and effective technique as an adjunct to conventional PCI and can improve clinical outcomes when used in the appropriate context. Its primary application currently is for lesions that are uncrossable or un-dilatable with conventional balloons. This article provides a concise review of the ELCA technique and focuses on its role in interventional cardiology. This activity reviews the basic concepts behind excimer lasers, indications and contraindications, procedural steps, potential complications, and highlights the role of the interprofessional team in evaluating and improving care for patients who undergo this procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for excimer laser coronary angioplasty.</p></list-item><list-item><p>Outline the equipment, preparation, and technique in regards to excimer laser coronary angioplasty.</p></list-item><list-item><p>Describe the appropriate evaluation and their potential complications and clinical significance of excimer laser coronary angioplasty.</p></list-item><list-item><p>Review strategies for improving outcomes from excimer laser coronary angioplasty.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21427&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21427">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21427.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Laser coronary angioplasty was introduced in the early 1980s, mainly to manage balloon-untreatable coronary artery lesions.<xref ref-type="bibr" rid="article-21427.r1">[1]</xref>&#x000a0;However, due to the huge cost of the laser system, disappointing results, and complications associated with the continuous waveform of argon and Nd: YAG lasers available at that time, it did not gain popularity.<xref ref-type="bibr" rid="article-21427.r2">[2]</xref><xref ref-type="bibr" rid="article-21427.r3">[3]</xref><xref ref-type="bibr" rid="article-21427.r4">[4]</xref><xref ref-type="bibr" rid="article-21427.r5">[5]</xref> Later in that decade, excimer lasers were developed.&#x000a0; Excimer, an acronym for the&#x000a0;<italic toggle="yes">excited dimer,</italic> produces ultraviolet laser energy pulsatile and short wavelength.&#x000a0; The pulsatile nature ensured the precise ablation of plaque tissue with insignificant thermal injury to the vessel.<xref ref-type="bibr" rid="article-21427.r6">[6]</xref>&#x000a0;The short wavelength through less depth of penetration, compared to the infra-red range of argon and Nd: YAG lasers, also limited collateral damage. Both of these properties of excimer lasers, in addition to improvement in catheter design, proper selection of patients, and development of safety protocols, played a crucial role in the reintroduction of laser technology in routine practice.<xref ref-type="bibr" rid="article-21427.r7">[7]</xref><xref ref-type="bibr" rid="article-21427.r8">[8]</xref><xref ref-type="bibr" rid="article-21427.r9">[9]</xref><xref ref-type="bibr" rid="article-21427.r10">[10]</xref>&#x000a0;In 1988, the first successful excimer laser coronary angioplasty (ELCA) was performed on a human subject at the Cedar Sinai Medical Center, Los Angeles.<xref ref-type="bibr" rid="article-21427.r11">[11]</xref></p>
      </sec>
      <sec id="article-21427.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Light amplification by stimulated emission of radiation, or LASER, in short, refers to the creation of high-energy, single-wavelength light beam from a gas mixture. For excimer lasers specifically, a mixture of xenon gas and diluted hydrogen chloride solution is used. After a high-voltage electrical discharge is passed through this gas mixture, excited dimers or <italic toggle="yes">excimers</italic>, xenon chloride (XeCl), are produced. These dimer molecules subsequently release photons with an ultraviolet (UV) wavelength. Mirror systems are then utilized to amplify this process and deliver the resulting high-energy laser beam to target tissues. On contact with tissue, this laser beam then modifies it via three major mechanisms, as detailed below:</p>
        <list list-type="order">
          <list-item>
            <p>Photochemical: Breakage of molecular bonds.</p>
          </list-item>
          <list-item>
            <p>Photothermal: Vibration of molecular bonds generates heat and leads to the vaporization of intracellular water, causing bubble formation. This ultimately leads to cell rupture.</p>
          </list-item>
          <list-item>
            <p>Photokinetic/photomechanical: The vapor bubbles generated secondary to the photothermal mechanism coalesce to form larger bubbles, further breaking down plaque tissue.</p>
          </list-item>
        </list>
        <p>The breakdown products generated from these biochemical processes are small enough (usually &#x0003c; 10 &#x000b5;m) to be rapidly cleared by the reticuloendothelial system of the body, hence preventing distal embolization.</p>
      </sec>
      <sec id="article-21427.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The Food and Drug Administration (FDA) currently approved indications for excimer laser coronary angioplasty (ELCA)&#x000a0;are<xref ref-type="bibr" rid="article-21427.r12">[12]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Balloon uncrossable and un-dilatable lesions</p>
          </list-item>
          <list-item>
            <p>Multi-focal, thrombotic saphenous vein graft lesions</p>
          </list-item>
          <list-item>
            <p>Chronic total occlusion (CTO)</p>
          </list-item>
          <list-item>
            <p>Moderately calcified lesions</p>
          </list-item>
          <list-item>
            <p>Ostial lesions</p>
          </list-item>
          <list-item>
            <p>Eccentric lesions</p>
          </list-item>
          <list-item>
            <p>Long lesions (&#x0003e; 20 mm)</p>
          </list-item>
          <list-item>
            <p>In-stent restenosis</p>
          </list-item>
        </list>
        <p>Besides, there have been reports of ELCA being utilized successfully for other indications, which are listed below:</p>
        <list list-type="order">
          <list-item>
            <p>Adjunctive to conventional percutaneous coronary intervention (PCI) for under-expanded/under-deployed stents, or in cases of large thrombus burden.<xref ref-type="bibr" rid="article-21427.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Modification of proximal cap of heavily calcified lesions, when initial attempts to cross with rotablation wire are unsuccessful.<xref ref-type="bibr" rid="article-21427.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21427.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no absolute contraindications for excimer laser coronary angioplasty (ELCA). Relative contraindications&#x000a0;include:<xref ref-type="bibr" rid="article-21427.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Acute angulation (&#x0003e; 45 degrees)</p>
          </list-item>
          <list-item>
            <p>Coronary dissection</p>
          </list-item>
          <list-item>
            <p>Unprotected left main coronary artery</p>
          </list-item>
        </list>
        <p>ELCA is also currently not recommended for poorly visualized/heavily calcified lesions and those with a diameter of less than the smallest catheter size available (0.9 mm).</p>
      </sec>
      <sec id="article-21427.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Excimer laser coronary angioplasty (ELCA) equipment includes an excimer laser-generator and catheters of variable sizes capable of delivering this laser energy. There is currently only one cardiovascular laser system approved for use in the United States by the FDA.<xref ref-type="bibr" rid="article-21427.r16">[16]</xref>&#x000a0;It generates a pulsed XeCl laser energy beam, which has a wavelength of 308 mm in the UV&#x02013;B range, tissue depth of penetration between 0-30 &#x000b5;m, outflow range of 30&#x000a0;to 80 mJ/mm (termed fluence), repetition rate between 25&#x000a0;to 80 pulses per second (Hz), and a duration (termed pulse width) range of 125&#x000a0;to 200 ns.</p>
        <p>ELCA catheters are currently available in four diameters (0.9 mm, 1.4 mm, 1.7 mm, and 2.0 mm), and are of two types based on the arrangement of fiberoptic fibers within the catheter. They can either be concentric around the guidewire lumen or eccentrically localized towards one hemisphere. Most commonly, the 0.9 mm catheter is used. Catheters can be conventional over-the-wire or newer rapid-exchange/monorail catheters. Monorail catheters are currently being utilized more commonly, given their advantages of better tip control and axial force transmission.</p>
      </sec>
      <sec id="article-21427.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>Before the initiation and throughout the procedure's length, all staff present inside the room, and the patient is required to wear tinted eye goggles to protect against corneal or retinal damage by the UV laser. The procedure should be done in a room with tinted windows and locked doors, and unauthorized access prohibited.</p>
        <p>Once turned on, the excimer laser generator requires around 5 minutes of start-up time. An appropriate catheter is then selected, and its central guidewire lumen flushed. General&#x000a0;concepts to consider when choosing a catheter are a) its size should not exceed two-thirds the diameter of the target vessel, and b) it should be able to deliver the intensity of energy needed to treat the target lesion based on the lesion&#x02019;s severity and consistency. Concentric catheters are most commonly utilized; however, eccentric catheters are recommended for in-stent restenosis, bifurcation lesions, and eccentric lesions since the laser beam can be rotated towards the target lesion using a torque knob.</p>
        <p>The proximal catheter end is then attached to the laser unit and its distal end calibrated. Calibration is an automated process, which is achieved by pointing the catheter tip towards the energy detector on the main laser unit and activating the laser. Subsequently, the laser unit enters into a standby mode.</p>
      </sec>
      <sec id="article-21427.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>A standard 0.014-inch PCI guidewire is typically advanced till it crosses the target lesion, after which the catheter is passed over it till its tip is in direct contact with the lesion. This is a major advantage of&#x000a0;excimer laser coronary angioplasty (ELCA) over other atherectomy techniques, which usually require dedicated guidewires. The desired fluence, pulse rate, and pulse width settings are then selected. By default, the system calibrates at 45 mJ/mm^2 at 25 Hz, with a pulse width of 135 ns. If resistance is encountered with these default settings, they can be increased in a stepwise fashion. This should be undertaken slowly since higher energies and frequencies&#x000a0;can be associated with a higher&#x000a0;chance of dissection and perforation complications.<xref ref-type="bibr" rid="article-21427.r15">[15]</xref>&#x000a0;The manufacturer recommends&#x000a0;that fluence be increased first rather than the frequency.</p>
        <p>A saline flush protocol is then employed before initiation of lasing. The concept behind this step is that both blood and contrast media consist of macromolecules, including proteins, that can absorb the bulk of the laser energy and lead to the formation of insoluble gas bubbles. This also increases the risk of complications such as intimal dissection and perforation.<xref ref-type="bibr" rid="article-21427.r8">[8]</xref><xref ref-type="bibr" rid="article-21427.r17">[17]</xref>&#x000a0;On the other hand, Saline provides a clear interface for the laser energy to be delivered directly to the target lesion. To perform the saline flush protocol, a 1 L bag of 0.9% normal saline is attached to one of the triple manifold ports via a three-way stopcock. The contrast syringe is replaced with a clean 20 cc syringe used for flushing contrast and blood from the entire system. Thereafter, the operator infuses a 5&#x000a0;to 10 cc bolus of normal saline through the guiding catheter, with the initiation of lasing immediately afterward. This is accompanied by a continuous infusion of normal saline at 1 to 3 mL/s throughout the duration of laser activation. The system is programmed to activate for 5 to 10 seconds, after which goes into a 5 to 10 second rest period. An audible alert will mark the end of this rest period, at which point the next lasing sequence can be commenced. This potentially helps avoid complications from prolonged laser energy exposure to the vessel.</p>
        <p>It is also recommended that the catheter be advanced at a slow rate (&#x0003c;1 mm/s) within the vessel lumen to allow the plaque tissue sufficient time to adequately absorb the light energy and result in optimal vaporization and debulking.<xref ref-type="bibr" rid="article-21427.r15">[15]</xref></p>
      </sec>
      <sec id="article-21427.s9" sec-type="Complications">
        <title>Complications</title>
        <p>With the optimization of laser catheters and the introduction of safety techniques such as the saline infusion protocol, the incidence of previously seen serious complications such as flow-limiting dissections and vessel perforations has significantly decreased.<xref ref-type="bibr" rid="article-21427.r8">[8]</xref><xref ref-type="bibr" rid="article-21427.r11">[11]</xref><xref ref-type="bibr" rid="article-21427.r18">[18]</xref>&#x000a0;Other measures that can prevent these adverse outcomes include avoiding excessive force and lasing on high settings for prolonged periods. Perforations are more likely to occur if an inappropriate size or type of catheter is used (for example, concentric for an eccentrically located lesion), or if energy is applied to a previously dissected segment.<xref ref-type="bibr" rid="article-21427.r15">[15]</xref>&#x000a0;If any of these complications occur, the lasing procedure should be aborted, and the complication managed per standard protocol.</p>
      </sec>
      <sec id="article-21427.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Excimer laser coronary angioplasty (ELCA) is a safe and effective technique as an adjunct to conventional PCI and can improve clinical outcomes when used in the appropriate context. As noted previously, its primary application currently is for lesions that are uncrossable or un-dilatable with conventional balloons.<xref ref-type="bibr" rid="article-21427.r19">[19]</xref>&#x000a0;In cases where even the laser catheter cannot cross the lesion, such as CTOs or heavily calcified lesions, the laser energy has been successfully utilized to modify the lesion's proximal cap.<xref ref-type="bibr" rid="article-21427.r14">[14]</xref>&#x000a0;This allows the passage of a standard PCI microcatheter or dedicated guidewire such as RotaWire later on, and the procedure can then be completed in a usual fashion.</p>
        <p>Another important application of ELCA is to debulk thrombotic occlusions in saphenous vein grafts (SVGs). These lesions are prone to distal embolization<xref ref-type="bibr" rid="article-21427.r20">[20]</xref>&#x000a0;and can cause no-reflow with standard SVG-PCI. Hence, it is recommended that distal protection devices (DPDs) be utilized to prevent this complication.<xref ref-type="bibr" rid="article-21427.r21">[21]</xref>&#x000a0;However, these devices are often bulky and unable to be delivered distally. ELCA has been shown to have a low rate of distal embolization and can be used as a safer alternative without DPDs for the majority of cases.<xref ref-type="bibr" rid="article-21427.r22">[22]</xref><xref ref-type="bibr" rid="article-21427.r23">[23]</xref></p>
        <p>The incidence of in-stent restenosis (ISR) has reduced considerably with the advent of drug-eluting stents (DES)<xref ref-type="bibr" rid="article-21427.r24">[24]</xref>, compared to bare-metal stents (BMS).<xref ref-type="bibr" rid="article-21427.r25">[25]</xref>&#x000a0;In those cases with ISR, ELCA is a safe technique that does not cause collateral damage to the stainless-steel stent.<xref ref-type="bibr" rid="article-21427.r26">[26]</xref>&#x000a0;Simultaneously, it achieves greater intravascular ultrasound (IVUS) cross-sectional area, luminal gain, and intimal hyperplasia ablation compared to balloon angioplasty alone.<xref ref-type="bibr" rid="article-21427.r27">[27]</xref><xref ref-type="bibr" rid="article-21427.r28">[28]</xref></p>
        <p>Additionally, since ELCA has been shown to ablate both the luminal and the abluminal plaque tissue<xref ref-type="bibr" rid="article-21427.r29">[29]</xref>, in those cases where an under-deployed stent was the cause of ISR, these stents can be better approximated to the vessel wall.<xref ref-type="bibr" rid="article-21427.r13">[13]</xref>&#x000a0;This can potentially prevent the need for future revascularization.</p>
      </sec>
      <sec id="article-21427.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Since&#x000a0;excimer laser coronary angioplasty (ELCA) is still a relatively new procedure, there are no evidence-based guidelines currently to ensure optimal outcomes. A "5<bold>S</bold>&#x000a0;approach"&#x000a0;has been suggested to achieve the best results from ELCA, which are<xref ref-type="bibr" rid="article-21427.r15">[15]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p><bold>S</bold>election of patient</p>
          </list-item>
          <list-item>
            <p><bold>S</bold>ize of the laser catheter</p>
          </list-item>
          <list-item>
            <p><bold>S</bold>ettings (fluence and pulse rate)</p>
          </list-item>
          <list-item>
            <p><bold>S</bold>aline infusion protocol</p>
          </list-item>
          <list-item>
            <p><bold>S</bold>low advancement</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21427.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21427&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21427">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21427/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21427">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21427.s13">
        <title>References</title>
        <ref id="article-21427.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Eigler</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Shefer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Forrester</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Litvack</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty.</article-title>
            <source>Circulation</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>632</fpage>
            <page-range>632-43</page-range>
            <pub-id pub-id-type="pmid">1860207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Appelman</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Piek</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Strikwerda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tijssen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>de Feyter</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Koelemay</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Montauban van Swijndregt</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Koolen</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease.</article-title>
            <source>Lancet</source>
            <year>1996</year>
            <month>Jan</month>
            <day>13</day>
            <volume>347</volume>
            <issue>8994</issue>
            <fpage>79</fpage>
            <page-range>79-84</page-range>
            <pub-id pub-id-type="pmid">8538345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reifart</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vandormael</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krajcar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f6;hring</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Preusler</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>St&#x000f6;rger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kl&#x000f6;pper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study.</article-title>
            <source>Circulation</source>
            <year>1997</year>
            <month>Jul</month>
            <day>01</day>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-8</page-range>
            <pub-id pub-id-type="pmid">9236422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Keaney</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Tcheng</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Isner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sanborn</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>1158</fpage>
            <page-range>1158-65</page-range>
            <pub-id pub-id-type="pmid">8459071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Topaz</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Whose fault is it? Notes on "true" versus "pseudo" laser failure.</article-title>
            <source>Cathet Cardiovasc Diagn</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">7489586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grundfest</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Litvack</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Forrester</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Swan</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McDermid</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Rider</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Pacala</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Laser ablation of human atherosclerotic plaque without adjacent tissue injury.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1985</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>929</fpage>
            <page-range>929-33</page-range>
            <pub-id pub-id-type="pmid">3838324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brinker</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sanborn</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Isner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tcheng</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty. Participating Investigators of the Percutaneous Excimer Laser Coronary Angioplasty Registry.</article-title>
            <source>J Interv Cardiol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>653</fpage>
            <page-range>653-60</page-range>
            <pub-id pub-id-type="pmid">10159756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deckelbaum</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rohlfs</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chisholm</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. The Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Investigators.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1995</year>
            <month>Nov</month>
            <day>01</day>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>1264</fpage>
            <page-range>1264-9</page-range>
            <pub-id pub-id-type="pmid">7594041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tcheng</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Saline infusion in excimer laser coronary angioplasty.</article-title>
            <source>Semin Interv Cardiol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-41</page-range>
            <pub-id pub-id-type="pmid">9552504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Topaz</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>A new, safer lasing technique for laser-facilitated coronary angioplasty.</article-title>
            <source>J Interv Cardiol</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>297</fpage>
            <page-range>297-306</page-range>
            <pub-id pub-id-type="pmid">10151024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Litvack</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Eigler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rothbaum</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bresnahan</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Untereker</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>323</fpage>
            <page-range>323-9</page-range>
            <pub-id pub-id-type="pmid">8294681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badr</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ben-Dor</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dvir</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barbash</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Kitabata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Minha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pendyala</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Torguson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Waksman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The state of the excimer laser for coronary intervention in the drug-eluting stent era.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2013</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-8</page-range>
            <pub-id pub-id-type="pmid">23332778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egred</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A novel approach for under-expanded stent: excimer laser in contrast medium.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>E161</fpage>
            <page-range>E161-3</page-range>
            <pub-id pub-id-type="pmid">22865316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egred</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>RASER angioplasty.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2012</year>
            <month>May</month>
            <day>01</day>
            <volume>79</volume>
            <issue>6</issue>
            <fpage>1009</fpage>
            <page-range>1009-12</page-range>
            <pub-id pub-id-type="pmid">22162119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egred</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brilakis</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Excimer Laser Coronary Angioplasty (ELCA): Fundamentals, Mechanism of Action, and Clinical Applications.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>E27</fpage>
            <page-range>E27-E35</page-range>
            <pub-id pub-id-type="pmid">32005787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawlins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Din</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Talwar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>O'Kane</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Coronary Intervention with the Excimer Laser: Review of the Technology and Outcome Data.</article-title>
            <source>Interv Cardiol</source>
            <year>2016</year>
            <month>May</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-32</page-range>
            <pub-id pub-id-type="pmid">29588701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumbach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oberhoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karsch</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Formation of pressure waves during in vitro excimer laser irradiation in whole blood and the effect of dilution with contrast media and saline.</article-title>
            <source>Lasers Surg Med</source>
            <year>1994</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-6</page-range>
            <pub-id pub-id-type="pmid">8127204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghazzal</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Hearn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Litvack</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Eigler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Morphological predictors of acute complications after percutaneous excimer laser coronary angioplasty. Results of a comprehensive angiographic analysis: importance of the eccentricity index.</article-title>
            <source>Circulation</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>820</fpage>
            <page-range>820-7</page-range>
            <pub-id pub-id-type="pmid">1516194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bilodeau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fretz</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Taeymans</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Koolen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hilton</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Novel use of a high-energy excimer laser catheter for calcified and complex coronary artery lesions.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-61</page-range>
            <pub-id pub-id-type="pmid">15170703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sanborn</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Yardley</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Tcheng</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Isner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chokshi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Abela</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Schmidhofer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry.</article-title>
            <source>Am J Cardiol</source>
            <year>1994</year>
            <month>Jul</month>
            <day>15</day>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-8</page-range>
            <pub-id pub-id-type="pmid">8023778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Wahr</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cutlip</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Kuntz</surname>
                <given-names>RE</given-names>
              </name>
              <collab>Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators</collab>
            </person-group>
            <article-title>Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.</article-title>
            <source>Circulation</source>
            <year>2002</year>
            <month>Mar</month>
            <day>19</day>
            <volume>105</volume>
            <issue>11</issue>
            <fpage>1285</fpage>
            <page-range>1285-90</page-range>
            <pub-id pub-id-type="pmid">11901037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giugliano</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Mego</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ebersole</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ruggio</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Maini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2012</year>
            <season>Mar-Apr</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <page-range>84-9</page-range>
            <pub-id pub-id-type="pmid">22406059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebersole</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dahm</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Madyoon</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hilton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alderman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Topaz</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>177</fpage>
            <page-range>177-80</page-range>
            <pub-id pub-id-type="pmid">15152140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dangas</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Claessen</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Caixeta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanidas</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>In-stent restenosis in the drug-eluting stent era.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2010</year>
            <month>Nov</month>
            <day>30</day>
            <volume>56</volume>
            <issue>23</issue>
            <fpage>1897</fpage>
            <page-range>1897-907</page-range>
            <pub-id pub-id-type="pmid">21109112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowe</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Oesterle</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Khachigian</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Coronary in-stent restenosis: current status and future strategies.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2002</year>
            <month>Jan</month>
            <day>16</day>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-93</page-range>
            <pub-id pub-id-type="pmid">11788206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lippincott</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Elfe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tcheng</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Reiser</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>555</fpage>
            <page-range>555-9</page-range>
            <pub-id pub-id-type="pmid">11060568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Satler</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bucher</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone.</article-title>
            <source>Circulation</source>
            <year>1997</year>
            <month>Oct</month>
            <day>07</day>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>2183</fpage>
            <page-range>2183-9</page-range>
            <pub-id pub-id-type="pmid">9337188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Taniike</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Egami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shutta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tanouchi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>478</fpage>
            <page-range>478-83</page-range>
            <pub-id pub-id-type="pmid">23043029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21427.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawlins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Talwar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Kane</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography following percutaneous coronary intervention with Excimer laser coronary atherectomy.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">24238883</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
